Infectious Disease
The Infectious Disease (ID) Research Program is dedicated to discovering better ways to diagnose, treat and prevent infectious diseases. Comprised of clinical investigators, research associates, nurses, microbiologists and laboratory technicians, our research program has had a considerable impact on the practice of clinical medicine, including changes in national and international policy and recommendations on the treatment and prevention of diseases in children.
Clinical Trials Within ID
At any given time, there could be 25 to 50 studies underway within ID ranging from small projects enrolling one to two patients with special needs to large studies involving thousands of subjects. Examples include:
- Studies defining the epidemiology of infectious disease pathogens
- Interventional trials of new antibiotics, antivirals or antifungals aimed at treating viruses, bacteria or fungi
- Molecular studies of pathogen transmission and spread within diverse settings, including the hospital, transplant units, daycare and communities - both in the United States and in developing countries
- Investigations determining the dosing and safety of new antiretroviral medications for HIV-infected children and interventions to improve the long-term health of HIV-infected children and adolescents
The Seattle Children’s Pediatric Infectious Disease Research Group, directed by Dr. Janet Englund, continues to study respiratory viruses such as SARS-CoV-2, the virus causing the disease known as COVID-19.
Marguerite study
Researchers at Seattle Children’s Hospital and the University of Washington are currently researching if a single dose of Pfizer’s RSV vaccine given during a pregnancy continues to offer protection in subsequent pregnancies. The Marguerite study will help determine how long protection lasts from the first maternal dose and whether a second dose is needed during later pregnancies.
If you are pregnant, you may be able to join the Marguerite study if you:
- Are between 18 and 49 years of age
- Received a dose of Pfizer’s RSV vaccine during a previous pregnancy
- Are expecting a single healthy baby
- Are able to be vaccinated during weeks 32-36 of your pregnancy
These are not the only qualifications needed to be in this study. The study team at Seattle Children’s and UW will be glad to give you all the details to help you decide if the study is right for you.
BEATRIX study
At birth, your baby’s immune system is not quite ready to fight infections on its own. That’s why researchers at Seattle Children’s Hospital and the University of Washington are researching an investigational maternal vaccine that is designed to protect pregnant women and their babies from the 6 most common types of GBS.
The BEATRIX study is enrolling pregnant women who are:
- 49 years of age or younger
- Expecting a single healthy baby
- Able to be vaccinated during weeks 24-36 of your pregnancy
These are not the only qualifications needed to be in this study. The study team at Seattle Children’s Hospital and UW will give you all the details to help you decide if the study is right for you and your baby.
ROUSSEAU study
While RSV causes mild, cold-like symptoms in most children, it can be serious in children and teens with weakened immune systems or certain health conditions that leave them vulnerable to RSV infection and disease.
The ROUSSEAU Study will help us learn if an RSV study vaccine is safe for children 5 to 17 years of age who are at high risk for RSV disease and if it can help their immune systems fight against RSV. The RSV vaccine being studied is currently approved for use in older adults and adults who are pregnant.
We invite families of every background to join us in developing vaccines that could help protect children against RSV. We’re currently enrolling kids with stable chronic medical conditions like asthma, cystic fibrosis, chronic lung disease, Trisomy 21, cerebral palsy, congenital heart disease, sickle cell disease and confirmed stable HIV.
- If you’re interested in joining the study or would like to learn more, give the Seattle Children’s Infectious Disease Research team a call at 206-884-1100 or send an email to [email protected].
You Can Make a Difference: Take Part in a Clinical Trial
Infectious diseases are the most common cause of morbidity and mortality in children and many of them are either preventable via vaccines or treatable with anti-infectives. Clinical research and trials focused on infectious diseases are essential to improving the health of children locally and globally. To take part in a clinical trial, please contact one of our research staff members, Amanda Adler or Kirsten Lacombe, MSN.
Help us answer questions about childhood health and illness, and help other children in the future. Learn more in Pediatric Clinical Trials and Research Studies.